You should contact your healthcare provider if your side effects are severe, worsen over time, or dont improve as your body adjusts
Generic naming and approval status can differ by country

Additional caution may be appropriate in research involving: Additional Monitoring May Be Considered In Research Models Involving: Pregnancy and lactation-related research contexts, where limited safety data is available Severe gastrointestinal or delayed gastric-emptying research models, where GLP-1related pathways may influence gastrointestinal motility-related observations Pancreatic or pancreatitis-related research models, where metabolic and digestive-signaling pathways may require additional monitoring Gallbladder or biliary-related research models, where gastrointestinal and metabolic pathway modulation may influence biliary-related observations Diabetes or glucose-regulation research models involving concurrent glucose-lowering compounds, where glucose-homeostasis pathways may require closer monitoring Severe hepatic or renal impairment research models, where metabolic clearance and tolerability observations may differ Thyroid-related research models, including investigations involving endocrine-signaling pathways, thyroid-related biomarkers, or thyroid-cancer history models Additional Research Considerations Research conditions, protocol structure, research amount, and concurrent compounds may influence tolerability observations across experimental settings

BPC-157 has been investigated in experimental settings involving ligament healing, contributing to growing interest in its potential role within regenerative medicine
The most common side effects are gastrointestinal symptoms like nausea, vomiting, and diarrhea